The role of aripiprazole in Canada: A review of clinical and drug discontinuation data. Foreword.
Roger S
RS
McIntyre
D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000068180:Aripiprazole; D002170:Canada; D002986:Clinical Trials as Topic; D015897:Comorbidity; D004363:Drug Utilization; D017723:Drug Utilization Review / Q000706:statistics & numerical data*; D006801:Humans; D008659:Metabolic Diseases / Q000139:chemically induced / Q000517:prevention & control; D019964:Mood Disorders / Q000188:drug therapy*; D010879:Piperazines / Q000009:adverse effects / Q000627:therapeutic use*; D011618:Psychotic Disorders / Q000188:drug therapy*; D015363:Quinolones / Q000009:adverse effects / Q000627:therapeutic use*; D012307:Risk Factors
D014150:Antipsychotic Agents; D010879:Piperazines; D015363:Quinolones; D000068180:Aripiprazole